REHAB

REHAB is indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids.The mechanism of action of REHAB in alcoholism is not understood. It is thought to act as a competitive antagonist at mc, κ, and δ receptors in the CNS, with the highest affinity for the µ receptor. REHAB competitively binds to such receptors and may block the effects of endogenous opioids. This leads to the antagonization of most of the subjective and objective effects of endogenous opiates, including respiratory depression, meiosis, euphoria, and drug craving.